The official launch of Plasmidsaurus RNA-Seq will take place at ASHG 2025 in Boston, where Plasmidsaurus will host ...
Stoke Therapeutics, Inc. , a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicines, today announced the presentation of two-year data ...
Discusses 2-Year Phase II Data and AI Immunology Platform in High-Risk Melanoma October 22, 2025 10:30 AM EDTCompany ...
On October 21, 10x Genomics, Inc. and Prognosys Biosciences, Inc. filed a complaint for patent infringement against Illumina, ...
Viridian Therapeutics, Inc. , a biotechnology company focused on discovering, developing and commercializing potentially best-in-class medicines for serious and rare diseases, today announced it ...
Nonfactor therapies may reduce costs associated with bleeding-related hospitalizations and use of bypassing agents. One study ...
The company says the system can benefit pharmaceutical and biotech firms seeking rapid feedback on drug candidates or genome editing.
Produced in Partnership with RNA ConnectReviewed by Maria OsipovaOct 10 2025 The UltraMarathonRT ® cDNA Synthesis and Amplification Kit delivers a comprehensive approach for copying polyA+ RNA into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback